Impact of Dyrk1A level on alcohol metabolism

Biochim Biophys Acta. 2016 Sep;1862(9):1495-503. doi: 10.1016/j.bbadis.2016.05.011. Epub 2016 May 20.

Abstract

Alcoholic liver diseases arise from complex phenotypes involving many genetic factors. It is quite common to find hyperhomocysteinemia in chronic alcoholic liver diseases, mainly due to deregulation of hepatic homocysteine metabolism. Dyrk1A, involved in homocysteine metabolism at different crossroads, is decreased in liver of hyperhomocysteinemic mice. Here, we hypothesized that Dyrk1A contributes to alcohol-induced hepatic impairment in mice. Control, hyperhomocysteinemic and mice overexpressing Dyrk1A were fed using a Lieber-DeCarli liquid diet with or without ethanol (5% v/v ethanol) for one month, and liver histological examination and liver biochemical function tests were performed. Plasma alanine aminotransferase and homocysteine levels were significantly decreased in mice overexpressing Dyrk1A compared to control mice with or without alcohol administration. On the contrary, the mean plasma alanine aminotransferase and homocysteine levels were significantly higher in hyperhomocysteinemic mice than that of control mice after alcohol administration. Paraoxonase 1 and CYP2E1, two phase I xenobiotic metabolizing enzymes, were found increased in the three groups of mice after alcohol administration. However, NQO1, a phase II enzyme, was only found increased in hyperhomocysteinemic mice after alcohol exposure, suggesting a greater effect of alcohol in liver of hyperhomocysteinemic mice. We observed positive correlations between hepatic alcohol dehydrogenase activity, Dyrk1A and ADH4 protein levels. Importantly, a deleterious effect of alcohol consumption on hepatic Dyrk1A protein level was found. Our study reveals on the one hand a role of Dyrk1A in ethanol metabolism and on the other hand a deleterious effect of alcohol administration on hepatic Dyrk1A level.

Keywords: Alcohol dehydrogenase; Ethanol; Hyperhomocysteinemia; Liver; Mice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alanine Transaminase / blood
  • Animals
  • Aryldialkylphosphatase / metabolism
  • Cystathionine beta-Synthase / deficiency
  • Cystathionine beta-Synthase / genetics
  • Cystathionine beta-Synthase / metabolism
  • Disease Models, Animal
  • Ethanol / administration & dosage
  • Ethanol / metabolism*
  • Ethanol / toxicity
  • Female
  • Homocysteine / metabolism
  • Humans
  • Hyperhomocysteinemia / etiology
  • Hyperhomocysteinemia / genetics
  • Hyperhomocysteinemia / metabolism
  • Liver / drug effects
  • Liver / metabolism
  • Liver / pathology
  • Liver Diseases, Alcoholic / complications
  • Liver Diseases, Alcoholic / genetics
  • Liver Diseases, Alcoholic / metabolism*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Transgenic
  • NAD(P)H Dehydrogenase (Quinone) / metabolism
  • Protein-Serine-Threonine Kinases / genetics
  • Protein-Serine-Threonine Kinases / metabolism*
  • Protein-Tyrosine Kinases / genetics
  • Protein-Tyrosine Kinases / metabolism*
  • Triglycerides / metabolism
  • Up-Regulation

Substances

  • Triglycerides
  • Homocysteine
  • Ethanol
  • NAD(P)H Dehydrogenase (Quinone)
  • Nqo1 protein, mouse
  • Alanine Transaminase
  • Dyrk kinase
  • Protein-Tyrosine Kinases
  • Protein-Serine-Threonine Kinases
  • Aryldialkylphosphatase
  • PON1 protein, mouse
  • Cystathionine beta-Synthase